Public consultations - closed 

Below are public consultations that have closed. The documents describe the outcomes of these public consultations.  

2024

Draft guide for health institutions who manufacture and use in-house in-vitro diagnostic medical devices in Ireland

Draft guide


2023

Proposed fees for 2024: Human Medicines, Compliance Activities, Blood, Tissue Establishments, Organs and Medical Devices

Public consultation

Outcome of the process

Proposed fees for 2024: Veterinary Medicinal Products

Public consultation

Outcome of the process


2022

Proposed fees for 2023: Veterinary Medicinal Products

Public consultation

Outcome of the process

Proposed fees 2023: Human Medicines, Compliance Activities, Blood, Tissue Establishments, Organs and Medical Devices

Public consultation

Outcome of the process

Registration of processes exempted under Article 61(5) and applicable requirements under Article 61(6) of the CTR

Public consultation

A document outlining the outcome of the process will be available at a later date.


2021

Proposed fees for veterinary medicinal products 2022

Public consultation 

Outcome of the process

Proposed fees for human medicines, compliance activities, blood, tissue establishments and organs and medical devices 2022

Public consultation 

Outcome of the process

Proposed fees for clinical trials 2022

Public consultation 

Outcome of the process


2020

Proposed fees for human medicines, compliance activities, blood and tissue establishments and organs 2021

Public consultation

Outcome of the process

Proposed fees for medical devices 2021

Public consultation

Outcome of the process

Proposed fees for veterinary medicines 2021

Public consultation

Outcome of the process

HPRA strategic plan 2021 – 2025

Launch of the public consultation

Final Strategic Plan 2021 - 2025


2019

Proposed fees for human medicines, medical devices, veterinary medicines and compliance 2020

Outcome of the process

Proposed fees for veterinary medicines 2020

Public consultation

Outcome of the process

Guide to biosimilars for healthcare professionals

Guide to biosimilars for healthcare professionals

Outcome of the process


2018

Proposed fees for human medicines, compliance activities, blood, tissue establishments and organs 2019

Public consultation

Outcome of the process

Proposed fees for veterinary medicinal products 2019

Public consultation

Outcome of the process

Proposed fees for medical devices 2018

Public consultation

Outcome of the process

Draft framework for multi-stakeholder approach to handling medicines shortages 2018

Draft framework document

Outcome of the process - final framework document


2017

Proposed fees for human medicines, compliance activities, blood, tissue establishments and organs 2018

Public consultation

Outcome of the process

Proposed fees for veterinary medicinal products 2018

Public consultation

Outcome of the process

EU legislation on blood, tissues and cells 2017

Stakeholder consultation 

Summary of responses


2016

Proposed fees for human medicines, compliance activities, blood, tissue establishments, organs and medical devices 2017

Public consultation

Outcome of the process

Proposed fees for veterinary medicinal products 2017

Public consultation  

Outcome of the process

Introduction of a fee-based funding model to support the conduct of medical device regulatory activities 2016

Public consultation

Outcome of the process